Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the efficacy and safety of β-d-mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial.
Fattahi MJ, Jamshidi AR, Mahmoudi M, Vojdanian M, Yekaninejad MS, Jafarnezhad-Ansariha F, Ahmadi H, Rehm BHA, Matsuo H, Cuzzocrea S, Hosseini M, Hashemi SN, Aghazadeh Z, Mirshafiey A. Fattahi MJ, et al. Among authors: aghazadeh z. Int Immunopharmacol. 2018 Jan;54:112-117. doi: 10.1016/j.intimp.2017.11.003. Epub 2017 Nov 8. Int Immunopharmacol. 2018. PMID: 29127910 Clinical Trial.
Preclinical and pharmacotoxicology evaluation of α-l-guluronic acid (G2013) as a non-steroidal anti-inflammatory drug with immunomodulatory property.
Nazeri S, Khadem Azarian S, Fattahi MJ, Sedaghat R, Tofighi Zavareh F, Aghazadeh Z, Abdollahi M, Mirshafiey A. Nazeri S, et al. Among authors: aghazadeh z. Immunopharmacol Immunotoxicol. 2017 Apr;39(2):59-65. doi: 10.1080/08923973.2017.1282512. Epub 2017 Feb 1. Immunopharmacol Immunotoxicol. 2017. PMID: 28145788
Anti-aging effects of M2000 (β-D-mannuronic acid) as a novel immunosuppressive drug on the enzymatic and non-enzymatic oxidative stress parameters in an experimental model.
Hosseini S, Abdollahi M, Azizi G, Fattahi MJ, Rastkari N, Zavareh FT, Aghazadeh Z, Mirshafiey A. Hosseini S, et al. Among authors: aghazadeh z. J Basic Clin Physiol Pharmacol. 2017 May 1;28(3):249-255. doi: 10.1515/jbcpp-2016-0092. J Basic Clin Physiol Pharmacol. 2017. PMID: 28207414
Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on IL17, RORγt, IL4 and GATA3 gene expressions in rheumatoid arthritis patients.
Barati A, Jamshidi AR, Ahmadi H, Aghazadeh Z, Mirshafiey A. Barati A, et al. Among authors: aghazadeh z. Drug Des Devel Ther. 2017 Mar 30;11:1027-1033. doi: 10.2147/DDDT.S129419. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28408801 Free PMC article.
A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of β-D-mannuronic acid in rheumatoid arthritis patients.
Ahmadi H, Jamshidi AR, Gharibdoost F, Mahmoudi M, Rastkari N, Mostafaei S, Fattahi MJ, Vojdanian M, Cuzzocrea S, Rehm BHA, Matsuo H, Hosseini M, Aghazadeh Z, Mortazavi-Jahromi SS, Mirshafiey A. Ahmadi H, et al. Among authors: aghazadeh z. Inflammopharmacology. 2018 Jun;26(3):737-745. doi: 10.1007/s10787-018-0475-z. Epub 2018 Apr 25. Inflammopharmacology. 2018. PMID: 29696564 Clinical Trial.
48 results